nodes	percent_of_prediction	percent_of_DWPC	metapath
Ezetimibe—coronary artery disease—atherosclerosis	0.298	1	CtDrD
Ezetimibe—ABCG8—atherosclerosis	0.137	0.416	CbGaD
Ezetimibe—SOAT1—atherosclerosis	0.104	0.315	CbGaD
Ezetimibe—ABCG5—atherosclerosis	0.0884	0.268	CbGaD
Ezetimibe—UGT1A3—Simvastatin—atherosclerosis	0.0252	0.113	CbGbCtD
Ezetimibe—UGT1A3—Lovastatin—atherosclerosis	0.0246	0.11	CbGbCtD
Ezetimibe—UGT2B7—Simvastatin—atherosclerosis	0.0182	0.0814	CbGbCtD
Ezetimibe—UGT2B7—Lovastatin—atherosclerosis	0.0178	0.0796	CbGbCtD
Ezetimibe—UGT1A1—Simvastatin—atherosclerosis	0.0157	0.0703	CbGbCtD
Ezetimibe—UGT1A1—Lovastatin—atherosclerosis	0.0154	0.0688	CbGbCtD
Ezetimibe—SLCO1B1—Rosuvastatin—atherosclerosis	0.0117	0.0524	CbGbCtD
Ezetimibe—SLCO1B1—Simvastatin—atherosclerosis	0.0109	0.0487	CbGbCtD
Ezetimibe—SLCO1B1—Pravastatin—atherosclerosis	0.0107	0.0476	CbGbCtD
Ezetimibe—SLCO1B1—Lovastatin—atherosclerosis	0.0107	0.0476	CbGbCtD
Ezetimibe—ABCC2—Simvastatin—atherosclerosis	0.00957	0.0428	CbGbCtD
Ezetimibe—ABCC2—Lovastatin—atherosclerosis	0.00936	0.0419	CbGbCtD
Ezetimibe—ABCC2—Pravastatin—atherosclerosis	0.00936	0.0419	CbGbCtD
Ezetimibe—ABCG2—Rosuvastatin—atherosclerosis	0.0093	0.0416	CbGbCtD
Ezetimibe—ABCG2—Pravastatin—atherosclerosis	0.00846	0.0379	CbGbCtD
Ezetimibe—ABCB1—Simvastatin—atherosclerosis	0.00312	0.0139	CbGbCtD
Ezetimibe—ABCB1—Pravastatin—atherosclerosis	0.00305	0.0136	CbGbCtD
Ezetimibe—ABCB1—Lovastatin—atherosclerosis	0.00305	0.0136	CbGbCtD
Ezetimibe—CYP3A4—Rosuvastatin—atherosclerosis	0.00201	0.00899	CbGbCtD
Ezetimibe—CYP3A4—Simvastatin—atherosclerosis	0.00187	0.00836	CbGbCtD
Ezetimibe—CYP3A4—Lovastatin—atherosclerosis	0.00183	0.00818	CbGbCtD
Ezetimibe—CYP3A4—Pravastatin—atherosclerosis	0.00183	0.00818	CbGbCtD
Ezetimibe—ABCG5—liver—atherosclerosis	0.00066	0.111	CbGeAlD
Ezetimibe—NPC1L1—liver—atherosclerosis	0.000621	0.104	CbGeAlD
Ezetimibe—ABCG8—liver—atherosclerosis	0.000589	0.0988	CbGeAlD
Ezetimibe—Fluspirilene—HRH1—atherosclerosis	0.000405	0.391	CrCbGaD
Ezetimibe—SOAT1—connective tissue—atherosclerosis	0.000395	0.0663	CbGeAlD
Ezetimibe—ANPEP—connective tissue—atherosclerosis	0.000378	0.0635	CbGeAlD
Ezetimibe—SOAT1—cardiovascular system—atherosclerosis	0.000344	0.0577	CbGeAlD
Ezetimibe—ANPEP—cardiovascular system—atherosclerosis	0.000329	0.0552	CbGeAlD
Ezetimibe—Flunarizine—HRH1—atherosclerosis	0.000328	0.317	CrCbGaD
Ezetimibe—SOAT1—adipose tissue—atherosclerosis	0.000303	0.0509	CbGeAlD
Ezetimibe—Pimozide—HRH1—atherosclerosis	0.000302	0.292	CrCbGaD
Ezetimibe—ANPEP—adipose tissue—atherosclerosis	0.00029	0.0487	CbGeAlD
Ezetimibe—UGT1A3—liver—atherosclerosis	0.000263	0.0441	CbGeAlD
Ezetimibe—UGT2B15—liver—atherosclerosis	0.000247	0.0415	CbGeAlD
Ezetimibe—SOAT1—liver—atherosclerosis	0.000213	0.0357	CbGeAlD
Ezetimibe—ANPEP—liver—atherosclerosis	0.000203	0.0341	CbGeAlD
Ezetimibe—UGT2B7—liver—atherosclerosis	0.000151	0.0254	CbGeAlD
Ezetimibe—ABCC3—adipose tissue—atherosclerosis	0.000145	0.0243	CbGeAlD
Ezetimibe—UGT1A1—liver—atherosclerosis	0.000128	0.0216	CbGeAlD
Ezetimibe—Cramp muscle—Lovastatin—atherosclerosis	0.000127	0.00181	CcSEcCtD
Ezetimibe—Amnesia—Pravastatin—atherosclerosis	0.000127	0.00181	CcSEcCtD
Ezetimibe—Menopausal symptoms—Pravastatin—atherosclerosis	0.000126	0.0018	CcSEcCtD
Ezetimibe—Neuropathy peripheral—Rosuvastatin—atherosclerosis	0.000126	0.00179	CcSEcCtD
Ezetimibe—Jaundice—Rosuvastatin—atherosclerosis	0.000125	0.00178	CcSEcCtD
Ezetimibe—Arthritis—Niacin—atherosclerosis	0.000125	0.00178	CcSEcCtD
Ezetimibe—Arthritis—Pravastatin—atherosclerosis	0.000123	0.00175	CcSEcCtD
Ezetimibe—Influenza—Lovastatin—atherosclerosis	0.000122	0.00174	CcSEcCtD
Ezetimibe—Hepatobiliary disease—Rosuvastatin—atherosclerosis	0.000121	0.00173	CcSEcCtD
Ezetimibe—Eosinophilia—Lovastatin—atherosclerosis	0.000121	0.00172	CcSEcCtD
Ezetimibe—Sinusitis—Rosuvastatin—atherosclerosis	0.00012	0.00172	CcSEcCtD
Ezetimibe—Pancreatitis—Lovastatin—atherosclerosis	0.00012	0.0017	CcSEcCtD
Ezetimibe—Cramp muscle—Simvastatin—atherosclerosis	0.000119	0.00169	CcSEcCtD
Ezetimibe—Gastritis—Simvastatin—atherosclerosis	0.000117	0.00167	CcSEcCtD
Ezetimibe—Muscular weakness—Simvastatin—atherosclerosis	0.000116	0.00166	CcSEcCtD
Ezetimibe—Hepatitis—Rosuvastatin—atherosclerosis	0.000115	0.00164	CcSEcCtD
Ezetimibe—Pharyngitis—Rosuvastatin—atherosclerosis	0.000114	0.00163	CcSEcCtD
Ezetimibe—Eosinophilia—Simvastatin—atherosclerosis	0.000113	0.00161	CcSEcCtD
Ezetimibe—Erectile dysfunction—Lovastatin—atherosclerosis	0.000112	0.0016	CcSEcCtD
Ezetimibe—Liver function test abnormal—Niacin—atherosclerosis	0.000112	0.00159	CcSEcCtD
Ezetimibe—Pancreatitis—Simvastatin—atherosclerosis	0.000112	0.00159	CcSEcCtD
Ezetimibe—Photosensitivity reaction—Lovastatin—atherosclerosis	0.000111	0.00159	CcSEcCtD
Ezetimibe—Liver function test abnormal—Pravastatin—atherosclerosis	0.00011	0.00157	CcSEcCtD
Ezetimibe—Cramp muscle—Pravastatin—atherosclerosis	0.000107	0.00153	CcSEcCtD
Ezetimibe—Muscular weakness—Niacin—atherosclerosis	0.000107	0.00152	CcSEcCtD
Ezetimibe—SLCO1B1—liver—atherosclerosis	0.000107	0.0179	CbGeAlD
Ezetimibe—Nasopharyngitis—Pravastatin—atherosclerosis	0.000107	0.00152	CcSEcCtD
Ezetimibe—Neuropathy peripheral—Lovastatin—atherosclerosis	0.000107	0.00152	CcSEcCtD
Ezetimibe—Upper respiratory tract infection—Simvastatin—atherosclerosis	0.000106	0.00151	CcSEcCtD
Ezetimibe—ABCB1—blood vessel—atherosclerosis	0.000106	0.0177	CbGeAlD
Ezetimibe—Muscular weakness—Pravastatin—atherosclerosis	0.000105	0.0015	CcSEcCtD
Ezetimibe—Alanine aminotransferase increased—Pravastatin—atherosclerosis	0.000105	0.0015	CcSEcCtD
Ezetimibe—Erectile dysfunction—Simvastatin—atherosclerosis	0.000105	0.0015	CcSEcCtD
Ezetimibe—Influenza—Niacin—atherosclerosis	0.000105	0.00149	CcSEcCtD
Ezetimibe—Photosensitivity reaction—Simvastatin—atherosclerosis	0.000104	0.00148	CcSEcCtD
Ezetimibe—Influenza—Pravastatin—atherosclerosis	0.000103	0.00147	CcSEcCtD
Ezetimibe—Eosinophilia—Pravastatin—atherosclerosis	0.000102	0.00146	CcSEcCtD
Ezetimibe—Sinusitis—Lovastatin—atherosclerosis	0.000102	0.00145	CcSEcCtD
Ezetimibe—ABCC3—liver—atherosclerosis	0.000101	0.017	CbGeAlD
Ezetimibe—Pancreatitis—Pravastatin—atherosclerosis	0.000101	0.00144	CcSEcCtD
Ezetimibe—Mental disorder—Rosuvastatin—atherosclerosis	0.000101	0.00144	CcSEcCtD
Ezetimibe—Neuropathy peripheral—Simvastatin—atherosclerosis	9.97e-05	0.00142	CcSEcCtD
Ezetimibe—Jaundice—Simvastatin—atherosclerosis	9.92e-05	0.00141	CcSEcCtD
Ezetimibe—Flatulence—Rosuvastatin—atherosclerosis	9.88e-05	0.00141	CcSEcCtD
Ezetimibe—Hepatitis—Lovastatin—atherosclerosis	9.76e-05	0.00139	CcSEcCtD
Ezetimibe—Erectile dysfunction—Niacin—atherosclerosis	9.65e-05	0.00138	CcSEcCtD
Ezetimibe—Upper respiratory tract infection—Pravastatin—atherosclerosis	9.59e-05	0.00137	CcSEcCtD
Ezetimibe—Sinusitis—Simvastatin—atherosclerosis	9.54e-05	0.00136	CcSEcCtD
Ezetimibe—Erectile dysfunction—Pravastatin—atherosclerosis	9.5e-05	0.00135	CcSEcCtD
Ezetimibe—Photosensitivity reaction—Pravastatin—atherosclerosis	9.42e-05	0.00134	CcSEcCtD
Ezetimibe—Erythema multiforme—Lovastatin—atherosclerosis	9.23e-05	0.00132	CcSEcCtD
Ezetimibe—Angioedema—Rosuvastatin—atherosclerosis	9.16e-05	0.00131	CcSEcCtD
Ezetimibe—Hepatitis—Simvastatin—atherosclerosis	9.13e-05	0.0013	CcSEcCtD
Ezetimibe—Jaundice—Niacin—atherosclerosis	9.11e-05	0.0013	CcSEcCtD
Ezetimibe—Flushing—Lovastatin—atherosclerosis	9.06e-05	0.00129	CcSEcCtD
Ezetimibe—Neuropathy peripheral—Pravastatin—atherosclerosis	9.02e-05	0.00128	CcSEcCtD
Ezetimibe—Jaundice—Pravastatin—atherosclerosis	8.97e-05	0.00128	CcSEcCtD
Ezetimibe—Cough—Rosuvastatin—atherosclerosis	8.75e-05	0.00125	CcSEcCtD
Ezetimibe—Erythema multiforme—Simvastatin—atherosclerosis	8.64e-05	0.00123	CcSEcCtD
Ezetimibe—Sinusitis—Pravastatin—atherosclerosis	8.63e-05	0.00123	CcSEcCtD
Ezetimibe—Alopecia—Lovastatin—atherosclerosis	8.63e-05	0.00123	CcSEcCtD
Ezetimibe—Arthralgia—Rosuvastatin—atherosclerosis	8.54e-05	0.00122	CcSEcCtD
Ezetimibe—Myalgia—Rosuvastatin—atherosclerosis	8.54e-05	0.00122	CcSEcCtD
Ezetimibe—Flushing—Simvastatin—atherosclerosis	8.48e-05	0.00121	CcSEcCtD
Ezetimibe—ABCG2—adipose tissue—atherosclerosis	8.42e-05	0.0141	CbGeAlD
Ezetimibe—Hepatitis—Niacin—atherosclerosis	8.39e-05	0.0012	CcSEcCtD
Ezetimibe—Flatulence—Lovastatin—atherosclerosis	8.38e-05	0.00119	CcSEcCtD
Ezetimibe—Oedema peripheral—Niacin—atherosclerosis	8.26e-05	0.00118	CcSEcCtD
Ezetimibe—Hepatitis—Pravastatin—atherosclerosis	8.26e-05	0.00118	CcSEcCtD
Ezetimibe—Confusional state—Rosuvastatin—atherosclerosis	8.25e-05	0.00118	CcSEcCtD
Ezetimibe—Back pain—Lovastatin—atherosclerosis	8.22e-05	0.00117	CcSEcCtD
Ezetimibe—Pharyngitis—Pravastatin—atherosclerosis	8.19e-05	0.00117	CcSEcCtD
Ezetimibe—Muscle spasms—Lovastatin—atherosclerosis	8.17e-05	0.00116	CcSEcCtD
Ezetimibe—Infection—Rosuvastatin—atherosclerosis	8.13e-05	0.00116	CcSEcCtD
Ezetimibe—ABCC2—liver—atherosclerosis	8.1e-05	0.0136	CbGeAlD
Ezetimibe—Alopecia—Simvastatin—atherosclerosis	8.07e-05	0.00115	CcSEcCtD
Ezetimibe—Nervous system disorder—Rosuvastatin—atherosclerosis	8.03e-05	0.00114	CcSEcCtD
Ezetimibe—Thrombocytopenia—Rosuvastatin—atherosclerosis	8.01e-05	0.00114	CcSEcCtD
Ezetimibe—Mental disorder—Simvastatin—atherosclerosis	8e-05	0.00114	CcSEcCtD
Ezetimibe—Erythema—Simvastatin—atherosclerosis	7.95e-05	0.00113	CcSEcCtD
Ezetimibe—Ill-defined disorder—Lovastatin—atherosclerosis	7.89e-05	0.00112	CcSEcCtD
Ezetimibe—Flatulence—Simvastatin—atherosclerosis	7.83e-05	0.00112	CcSEcCtD
Ezetimibe—Erythema multiforme—Pravastatin—atherosclerosis	7.81e-05	0.00111	CcSEcCtD
Ezetimibe—Flushing—Niacin—atherosclerosis	7.78e-05	0.00111	CcSEcCtD
Ezetimibe—Angioedema—Lovastatin—atherosclerosis	7.77e-05	0.00111	CcSEcCtD
Ezetimibe—Malaise—Lovastatin—atherosclerosis	7.66e-05	0.00109	CcSEcCtD
Ezetimibe—Flushing—Pravastatin—atherosclerosis	7.66e-05	0.00109	CcSEcCtD
Ezetimibe—Muscle spasms—Simvastatin—atherosclerosis	7.64e-05	0.00109	CcSEcCtD
Ezetimibe—Angiopathy—Niacin—atherosclerosis	7.61e-05	0.00108	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	7.46e-05	0.00106	CcSEcCtD
Ezetimibe—Alopecia—Niacin—atherosclerosis	7.41e-05	0.00106	CcSEcCtD
Ezetimibe—Insomnia—Rosuvastatin—atherosclerosis	7.4e-05	0.00106	CcSEcCtD
Ezetimibe—Ill-defined disorder—Simvastatin—atherosclerosis	7.38e-05	0.00105	CcSEcCtD
Ezetimibe—Paraesthesia—Rosuvastatin—atherosclerosis	7.35e-05	0.00105	CcSEcCtD
Ezetimibe—Anaemia—Simvastatin—atherosclerosis	7.35e-05	0.00105	CcSEcCtD
Ezetimibe—Erythema—Niacin—atherosclerosis	7.3e-05	0.00104	CcSEcCtD
Ezetimibe—Malnutrition—Niacin—atherosclerosis	7.3e-05	0.00104	CcSEcCtD
Ezetimibe—Alopecia—Pravastatin—atherosclerosis	7.3e-05	0.00104	CcSEcCtD
Ezetimibe—Angioedema—Simvastatin—atherosclerosis	7.26e-05	0.00104	CcSEcCtD
Ezetimibe—Arthralgia—Lovastatin—atherosclerosis	7.24e-05	0.00103	CcSEcCtD
Ezetimibe—Myalgia—Lovastatin—atherosclerosis	7.24e-05	0.00103	CcSEcCtD
Ezetimibe—Chest pain—Lovastatin—atherosclerosis	7.24e-05	0.00103	CcSEcCtD
Ezetimibe—Dyspepsia—Rosuvastatin—atherosclerosis	7.21e-05	0.00103	CcSEcCtD
Ezetimibe—Flatulence—Niacin—atherosclerosis	7.19e-05	0.00103	CcSEcCtD
Ezetimibe—Malaise—Simvastatin—atherosclerosis	7.17e-05	0.00102	CcSEcCtD
Ezetimibe—Discomfort—Lovastatin—atherosclerosis	7.15e-05	0.00102	CcSEcCtD
Ezetimibe—Flatulence—Pravastatin—atherosclerosis	7.08e-05	0.00101	CcSEcCtD
Ezetimibe—Dry mouth—Lovastatin—atherosclerosis	7.08e-05	0.00101	CcSEcCtD
Ezetimibe—Muscle spasms—Niacin—atherosclerosis	7.02e-05	0.001	CcSEcCtD
Ezetimibe—Pain—Rosuvastatin—atherosclerosis	7e-05	0.000998	CcSEcCtD
Ezetimibe—Constipation—Rosuvastatin—atherosclerosis	7e-05	0.000998	CcSEcCtD
Ezetimibe—Confusional state—Lovastatin—atherosclerosis	6.99e-05	0.000997	CcSEcCtD
Ezetimibe—Anaphylactic shock—Lovastatin—atherosclerosis	6.94e-05	0.000989	CcSEcCtD
Ezetimibe—Muscle spasms—Pravastatin—atherosclerosis	6.91e-05	0.000985	CcSEcCtD
Ezetimibe—Infection—Lovastatin—atherosclerosis	6.89e-05	0.000982	CcSEcCtD
Ezetimibe—Thrombocytopenia—Lovastatin—atherosclerosis	6.79e-05	0.000968	CcSEcCtD
Ezetimibe—Arthralgia—Simvastatin—atherosclerosis	6.77e-05	0.000965	CcSEcCtD
Ezetimibe—Chest pain—Simvastatin—atherosclerosis	6.77e-05	0.000965	CcSEcCtD
Ezetimibe—Myalgia—Simvastatin—atherosclerosis	6.77e-05	0.000965	CcSEcCtD
Ezetimibe—Feeling abnormal—Rosuvastatin—atherosclerosis	6.75e-05	0.000961	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Rosuvastatin—atherosclerosis	6.69e-05	0.000954	CcSEcCtD
Ezetimibe—Discomfort—Simvastatin—atherosclerosis	6.69e-05	0.000953	CcSEcCtD
Ezetimibe—Angioedema—Niacin—atherosclerosis	6.67e-05	0.000951	CcSEcCtD
Ezetimibe—Ill-defined disorder—Pravastatin—atherosclerosis	6.67e-05	0.00095	CcSEcCtD
Ezetimibe—Anaemia—Pravastatin—atherosclerosis	6.64e-05	0.000947	CcSEcCtD
Ezetimibe—Angioedema—Pravastatin—atherosclerosis	6.57e-05	0.000936	CcSEcCtD
Ezetimibe—Confusional state—Simvastatin—atherosclerosis	6.54e-05	0.000932	CcSEcCtD
Ezetimibe—Urticaria—Rosuvastatin—atherosclerosis	6.5e-05	0.000927	CcSEcCtD
Ezetimibe—Anaphylactic shock—Simvastatin—atherosclerosis	6.49e-05	0.000925	CcSEcCtD
Ezetimibe—Malaise—Pravastatin—atherosclerosis	6.48e-05	0.000924	CcSEcCtD
Ezetimibe—Abdominal pain—Rosuvastatin—atherosclerosis	6.47e-05	0.000922	CcSEcCtD
Ezetimibe—Palpitations—Niacin—atherosclerosis	6.45e-05	0.000919	CcSEcCtD
Ezetimibe—Infection—Simvastatin—atherosclerosis	6.45e-05	0.000919	CcSEcCtD
Ezetimibe—Cough—Niacin—atherosclerosis	6.37e-05	0.000908	CcSEcCtD
Ezetimibe—Thrombocytopenia—Simvastatin—atherosclerosis	6.35e-05	0.000905	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Lovastatin—atherosclerosis	6.32e-05	0.000901	CcSEcCtD
Ezetimibe—Insomnia—Lovastatin—atherosclerosis	6.27e-05	0.000894	CcSEcCtD
Ezetimibe—Cough—Pravastatin—atherosclerosis	6.27e-05	0.000894	CcSEcCtD
Ezetimibe—Paraesthesia—Lovastatin—atherosclerosis	6.23e-05	0.000888	CcSEcCtD
Ezetimibe—Arthralgia—Niacin—atherosclerosis	6.21e-05	0.000886	CcSEcCtD
Ezetimibe—Myalgia—Niacin—atherosclerosis	6.21e-05	0.000886	CcSEcCtD
Ezetimibe—Hypertension—Pravastatin—atherosclerosis	6.21e-05	0.000884	CcSEcCtD
Ezetimibe—Dyspnoea—Lovastatin—atherosclerosis	6.18e-05	0.000881	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	6.17e-05	0.00088	CcSEcCtD
Ezetimibe—Myalgia—Pravastatin—atherosclerosis	6.12e-05	0.000872	CcSEcCtD
Ezetimibe—Chest pain—Pravastatin—atherosclerosis	6.12e-05	0.000872	CcSEcCtD
Ezetimibe—Arthralgia—Pravastatin—atherosclerosis	6.12e-05	0.000872	CcSEcCtD
Ezetimibe—Dyspepsia—Lovastatin—atherosclerosis	6.11e-05	0.00087	CcSEcCtD
Ezetimibe—Dry mouth—Niacin—atherosclerosis	6.08e-05	0.000866	CcSEcCtD
Ezetimibe—Discomfort—Pravastatin—atherosclerosis	6.05e-05	0.000862	CcSEcCtD
Ezetimibe—Hypersensitivity—Rosuvastatin—atherosclerosis	6.03e-05	0.000859	CcSEcCtD
Ezetimibe—Decreased appetite—Lovastatin—atherosclerosis	6.03e-05	0.000859	CcSEcCtD
Ezetimibe—Fatigue—Lovastatin—atherosclerosis	5.98e-05	0.000852	CcSEcCtD
Ezetimibe—Anaphylactic shock—Niacin—atherosclerosis	5.96e-05	0.000849	CcSEcCtD
Ezetimibe—Constipation—Lovastatin—atherosclerosis	5.93e-05	0.000845	CcSEcCtD
Ezetimibe—Pain—Lovastatin—atherosclerosis	5.93e-05	0.000845	CcSEcCtD
Ezetimibe—Confusional state—Pravastatin—atherosclerosis	5.91e-05	0.000843	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Simvastatin—atherosclerosis	5.91e-05	0.000842	CcSEcCtD
Ezetimibe—ABCG2—liver—atherosclerosis	5.91e-05	0.00992	CbGeAlD
Ezetimibe—Asthenia—Rosuvastatin—atherosclerosis	5.87e-05	0.000837	CcSEcCtD
Ezetimibe—Insomnia—Simvastatin—atherosclerosis	5.87e-05	0.000836	CcSEcCtD
Ezetimibe—Anaphylactic shock—Pravastatin—atherosclerosis	5.87e-05	0.000836	CcSEcCtD
Ezetimibe—Infection—Pravastatin—atherosclerosis	5.83e-05	0.000831	CcSEcCtD
Ezetimibe—Paraesthesia—Simvastatin—atherosclerosis	5.83e-05	0.00083	CcSEcCtD
Ezetimibe—Pruritus—Rosuvastatin—atherosclerosis	5.79e-05	0.000825	CcSEcCtD
Ezetimibe—Skin disorder—Niacin—atherosclerosis	5.79e-05	0.000825	CcSEcCtD
Ezetimibe—Dyspnoea—Simvastatin—atherosclerosis	5.78e-05	0.000824	CcSEcCtD
Ezetimibe—Thrombocytopenia—Pravastatin—atherosclerosis	5.74e-05	0.000819	CcSEcCtD
Ezetimibe—Feeling abnormal—Lovastatin—atherosclerosis	5.72e-05	0.000815	CcSEcCtD
Ezetimibe—Dyspepsia—Simvastatin—atherosclerosis	5.71e-05	0.000814	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Lovastatin—atherosclerosis	5.67e-05	0.000808	CcSEcCtD
Ezetimibe—Decreased appetite—Simvastatin—atherosclerosis	5.64e-05	0.000804	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Simvastatin—atherosclerosis	5.6e-05	0.000798	CcSEcCtD
Ezetimibe—Diarrhoea—Rosuvastatin—atherosclerosis	5.6e-05	0.000798	CcSEcCtD
Ezetimibe—Fatigue—Simvastatin—atherosclerosis	5.59e-05	0.000797	CcSEcCtD
Ezetimibe—Pain—Simvastatin—atherosclerosis	5.55e-05	0.000791	CcSEcCtD
Ezetimibe—Constipation—Simvastatin—atherosclerosis	5.55e-05	0.000791	CcSEcCtD
Ezetimibe—Urticaria—Lovastatin—atherosclerosis	5.51e-05	0.000785	CcSEcCtD
Ezetimibe—Abdominal pain—Lovastatin—atherosclerosis	5.48e-05	0.000782	CcSEcCtD
Ezetimibe—Body temperature increased—Lovastatin—atherosclerosis	5.48e-05	0.000782	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Niacin—atherosclerosis	5.43e-05	0.000774	CcSEcCtD
Ezetimibe—Dizziness—Rosuvastatin—atherosclerosis	5.41e-05	0.000771	CcSEcCtD
Ezetimibe—Insomnia—Niacin—atherosclerosis	5.39e-05	0.000768	CcSEcCtD
Ezetimibe—Paraesthesia—Niacin—atherosclerosis	5.35e-05	0.000762	CcSEcCtD
Ezetimibe—Feeling abnormal—Simvastatin—atherosclerosis	5.35e-05	0.000762	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Pravastatin—atherosclerosis	5.34e-05	0.000762	CcSEcCtD
Ezetimibe—Dyspnoea—Niacin—atherosclerosis	5.31e-05	0.000757	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Simvastatin—atherosclerosis	5.31e-05	0.000756	CcSEcCtD
Ezetimibe—Insomnia—Pravastatin—atherosclerosis	5.31e-05	0.000756	CcSEcCtD
Ezetimibe—Paraesthesia—Pravastatin—atherosclerosis	5.27e-05	0.000751	CcSEcCtD
Ezetimibe—Dyspepsia—Niacin—atherosclerosis	5.24e-05	0.000747	CcSEcCtD
Ezetimibe—Dyspnoea—Pravastatin—atherosclerosis	5.23e-05	0.000745	CcSEcCtD
Ezetimibe—Decreased appetite—Niacin—atherosclerosis	5.18e-05	0.000738	CcSEcCtD
Ezetimibe—Dyspepsia—Pravastatin—atherosclerosis	5.16e-05	0.000736	CcSEcCtD
Ezetimibe—Rash—Rosuvastatin—atherosclerosis	5.16e-05	0.000736	CcSEcCtD
Ezetimibe—Dermatitis—Rosuvastatin—atherosclerosis	5.16e-05	0.000735	CcSEcCtD
Ezetimibe—Urticaria—Simvastatin—atherosclerosis	5.15e-05	0.000735	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Niacin—atherosclerosis	5.14e-05	0.000733	CcSEcCtD
Ezetimibe—Abdominal pain—Simvastatin—atherosclerosis	5.13e-05	0.000731	CcSEcCtD
Ezetimibe—Body temperature increased—Simvastatin—atherosclerosis	5.13e-05	0.000731	CcSEcCtD
Ezetimibe—Headache—Rosuvastatin—atherosclerosis	5.13e-05	0.000731	CcSEcCtD
Ezetimibe—Hypersensitivity—Lovastatin—atherosclerosis	5.11e-05	0.000728	CcSEcCtD
Ezetimibe—Decreased appetite—Pravastatin—atherosclerosis	5.1e-05	0.000727	CcSEcCtD
Ezetimibe—Pain—Niacin—atherosclerosis	5.09e-05	0.000726	CcSEcCtD
Ezetimibe—Fatigue—Pravastatin—atherosclerosis	5.06e-05	0.000721	CcSEcCtD
Ezetimibe—Pain—Pravastatin—atherosclerosis	5.02e-05	0.000715	CcSEcCtD
Ezetimibe—Constipation—Pravastatin—atherosclerosis	5.02e-05	0.000715	CcSEcCtD
Ezetimibe—Asthenia—Lovastatin—atherosclerosis	4.98e-05	0.000709	CcSEcCtD
Ezetimibe—Pruritus—Lovastatin—atherosclerosis	4.91e-05	0.000699	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Niacin—atherosclerosis	4.87e-05	0.000694	CcSEcCtD
Ezetimibe—Nausea—Rosuvastatin—atherosclerosis	4.86e-05	0.000693	CcSEcCtD
Ezetimibe—Feeling abnormal—Pravastatin—atherosclerosis	4.83e-05	0.000689	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Pravastatin—atherosclerosis	4.8e-05	0.000684	CcSEcCtD
Ezetimibe—Hypersensitivity—Simvastatin—atherosclerosis	4.78e-05	0.000681	CcSEcCtD
Ezetimibe—Diarrhoea—Lovastatin—atherosclerosis	4.75e-05	0.000676	CcSEcCtD
Ezetimibe—Urticaria—Niacin—atherosclerosis	4.73e-05	0.000675	CcSEcCtD
Ezetimibe—ABCB1—cardiovascular system—atherosclerosis	4.71e-05	0.00791	CbGeAlD
Ezetimibe—Abdominal pain—Niacin—atherosclerosis	4.71e-05	0.000671	CcSEcCtD
Ezetimibe—Body temperature increased—Niacin—atherosclerosis	4.71e-05	0.000671	CcSEcCtD
Ezetimibe—Urticaria—Pravastatin—atherosclerosis	4.66e-05	0.000664	CcSEcCtD
Ezetimibe—Asthenia—Simvastatin—atherosclerosis	4.66e-05	0.000663	CcSEcCtD
Ezetimibe—Abdominal pain—Pravastatin—atherosclerosis	4.64e-05	0.000661	CcSEcCtD
Ezetimibe—Body temperature increased—Pravastatin—atherosclerosis	4.64e-05	0.000661	CcSEcCtD
Ezetimibe—Pruritus—Simvastatin—atherosclerosis	4.59e-05	0.000654	CcSEcCtD
Ezetimibe—Dizziness—Lovastatin—atherosclerosis	4.59e-05	0.000654	CcSEcCtD
Ezetimibe—Diarrhoea—Simvastatin—atherosclerosis	4.44e-05	0.000633	CcSEcCtD
Ezetimibe—Vomiting—Lovastatin—atherosclerosis	4.41e-05	0.000629	CcSEcCtD
Ezetimibe—Hypersensitivity—Niacin—atherosclerosis	4.39e-05	0.000626	CcSEcCtD
Ezetimibe—Rash—Lovastatin—atherosclerosis	4.37e-05	0.000623	CcSEcCtD
Ezetimibe—Dermatitis—Lovastatin—atherosclerosis	4.37e-05	0.000623	CcSEcCtD
Ezetimibe—Headache—Lovastatin—atherosclerosis	4.35e-05	0.000619	CcSEcCtD
Ezetimibe—Hypersensitivity—Pravastatin—atherosclerosis	4.32e-05	0.000616	CcSEcCtD
Ezetimibe—Dizziness—Simvastatin—atherosclerosis	4.29e-05	0.000611	CcSEcCtD
Ezetimibe—Asthenia—Niacin—atherosclerosis	4.27e-05	0.000609	CcSEcCtD
Ezetimibe—Pruritus—Niacin—atherosclerosis	4.22e-05	0.000601	CcSEcCtD
Ezetimibe—Asthenia—Pravastatin—atherosclerosis	4.21e-05	0.0006	CcSEcCtD
Ezetimibe—ABCB1—adipose tissue—atherosclerosis	4.15e-05	0.00697	CbGeAlD
Ezetimibe—Pruritus—Pravastatin—atherosclerosis	4.15e-05	0.000591	CcSEcCtD
Ezetimibe—Vomiting—Simvastatin—atherosclerosis	4.13e-05	0.000588	CcSEcCtD
Ezetimibe—Nausea—Lovastatin—atherosclerosis	4.12e-05	0.000587	CcSEcCtD
Ezetimibe—CYP3A4—liver—atherosclerosis	4.11e-05	0.00691	CbGeAlD
Ezetimibe—Rash—Simvastatin—atherosclerosis	4.09e-05	0.000583	CcSEcCtD
Ezetimibe—Dermatitis—Simvastatin—atherosclerosis	4.09e-05	0.000583	CcSEcCtD
Ezetimibe—Diarrhoea—Niacin—atherosclerosis	4.08e-05	0.000581	CcSEcCtD
Ezetimibe—Headache—Simvastatin—atherosclerosis	4.06e-05	0.000579	CcSEcCtD
Ezetimibe—Diarrhoea—Pravastatin—atherosclerosis	4.01e-05	0.000572	CcSEcCtD
Ezetimibe—Dizziness—Niacin—atherosclerosis	3.94e-05	0.000561	CcSEcCtD
Ezetimibe—Dizziness—Pravastatin—atherosclerosis	3.88e-05	0.000553	CcSEcCtD
Ezetimibe—Nausea—Simvastatin—atherosclerosis	3.85e-05	0.000549	CcSEcCtD
Ezetimibe—Vomiting—Niacin—atherosclerosis	3.79e-05	0.00054	CcSEcCtD
Ezetimibe—Rash—Niacin—atherosclerosis	3.76e-05	0.000535	CcSEcCtD
Ezetimibe—Dermatitis—Niacin—atherosclerosis	3.75e-05	0.000535	CcSEcCtD
Ezetimibe—Headache—Niacin—atherosclerosis	3.73e-05	0.000532	CcSEcCtD
Ezetimibe—Vomiting—Pravastatin—atherosclerosis	3.73e-05	0.000532	CcSEcCtD
Ezetimibe—Rash—Pravastatin—atherosclerosis	3.7e-05	0.000527	CcSEcCtD
Ezetimibe—Dermatitis—Pravastatin—atherosclerosis	3.7e-05	0.000527	CcSEcCtD
Ezetimibe—Headache—Pravastatin—atherosclerosis	3.67e-05	0.000524	CcSEcCtD
Ezetimibe—Nausea—Niacin—atherosclerosis	3.54e-05	0.000504	CcSEcCtD
Ezetimibe—Nausea—Pravastatin—atherosclerosis	3.48e-05	0.000497	CcSEcCtD
Ezetimibe—ABCB1—liver—atherosclerosis	2.91e-05	0.00489	CbGeAlD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.76e-06	2.47e-05	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—PTGS2—atherosclerosis	1.76e-06	2.46e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—CETP—atherosclerosis	1.75e-06	2.46e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—APOB—atherosclerosis	1.72e-06	2.4e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—SCARB1—atherosclerosis	1.71e-06	2.4e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—NAMPT—atherosclerosis	1.71e-06	2.4e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.7e-06	2.38e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—LIPC—atherosclerosis	1.7e-06	2.38e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.7e-06	2.38e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—APOC3—atherosclerosis	1.69e-06	2.37e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—LDLR—atherosclerosis	1.68e-06	2.35e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—GSTM1—atherosclerosis	1.67e-06	2.34e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—CETP—atherosclerosis	1.64e-06	2.3e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—LPL—atherosclerosis	1.64e-06	2.29e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—HMGCR—atherosclerosis	1.62e-06	2.27e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	1.6e-06	2.25e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—GPX1—atherosclerosis	1.6e-06	2.24e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—NAMPT—atherosclerosis	1.58e-06	2.22e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—LIPC—atherosclerosis	1.57e-06	2.2e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—SCARB1—atherosclerosis	1.57e-06	2.2e-05	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—AKT1—atherosclerosis	1.57e-06	2.2e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—APOC3—atherosclerosis	1.56e-06	2.19e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—CD36—atherosclerosis	1.56e-06	2.18e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—LDLR—atherosclerosis	1.55e-06	2.18e-05	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—ALB—atherosclerosis	1.55e-06	2.17e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—PLAT—atherosclerosis	1.54e-06	2.16e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.53e-06	2.14e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—HMOX1—atherosclerosis	1.52e-06	2.13e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—HMOX1—atherosclerosis	1.52e-06	2.13e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CETP—atherosclerosis	1.52e-06	2.13e-05	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—AKT1—atherosclerosis	1.51e-06	2.11e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—HMGCR—atherosclerosis	1.48e-06	2.08e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—MTHFR—atherosclerosis	1.47e-06	2.07e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—APOB—atherosclerosis	1.46e-06	2.04e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—APOB—atherosclerosis	1.46e-06	2.04e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—SCARB1—atherosclerosis	1.45e-06	2.04e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—ALB—atherosclerosis	1.45e-06	2.04e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PPARA—atherosclerosis	1.45e-06	2.03e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—ABCA1—atherosclerosis	1.44e-06	2.02e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—GSTM1—atherosclerosis	1.42e-06	1.99e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—GSTM1—atherosclerosis	1.42e-06	1.99e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ABCG1—atherosclerosis	1.41e-06	1.98e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—AGT—atherosclerosis	1.4e-06	1.96e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—LPL—atherosclerosis	1.39e-06	1.95e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—LPL—atherosclerosis	1.39e-06	1.95e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	1.39e-06	1.95e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—HMGCR—atherosclerosis	1.37e-06	1.92e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—APOE—atherosclerosis	1.37e-06	1.92e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	1.37e-06	1.92e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—CAV1—atherosclerosis	1.36e-06	1.91e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—GPX1—atherosclerosis	1.36e-06	1.9e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—GPX1—atherosclerosis	1.36e-06	1.9e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—APOA1—atherosclerosis	1.36e-06	1.9e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	1.35e-06	1.89e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—ALB—atherosclerosis	1.35e-06	1.89e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.34e-06	1.87e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—FABP4—atherosclerosis	1.33e-06	1.86e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—LCAT—atherosclerosis	1.33e-06	1.86e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—CD36—atherosclerosis	1.32e-06	1.85e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—CD36—atherosclerosis	1.32e-06	1.85e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—ABCA1—atherosclerosis	1.32e-06	1.85e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—PLG—atherosclerosis	1.31e-06	1.84e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—APOA4—atherosclerosis	1.3e-06	1.83e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CYP7A1—atherosclerosis	1.28e-06	1.79e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PLTP—atherosclerosis	1.27e-06	1.78e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	1.26e-06	1.77e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—MTHFR—atherosclerosis	1.25e-06	1.76e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—MTHFR—atherosclerosis	1.25e-06	1.76e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PIK3CG—atherosclerosis	1.24e-06	1.74e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—HMOX1—atherosclerosis	1.24e-06	1.73e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PPARA—atherosclerosis	1.23e-06	1.72e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PPARA—atherosclerosis	1.23e-06	1.72e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—ABCA1—atherosclerosis	1.22e-06	1.71e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	1.21e-06	1.7e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PPARG—atherosclerosis	1.2e-06	1.68e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	1.19e-06	1.67e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—AGT—atherosclerosis	1.19e-06	1.67e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—AGT—atherosclerosis	1.19e-06	1.67e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—APOB—atherosclerosis	1.19e-06	1.66e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CYP27A1—atherosclerosis	1.18e-06	1.66e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—INS—atherosclerosis	1.17e-06	1.64e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—APOE—atherosclerosis	1.17e-06	1.64e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—APOE—atherosclerosis	1.17e-06	1.64e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—APOB—atherosclerosis	1.16e-06	1.63e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	1.16e-06	1.62e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—CAV1—atherosclerosis	1.16e-06	1.62e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—CAV1—atherosclerosis	1.16e-06	1.62e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—APOA1—atherosclerosis	1.15e-06	1.62e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—APOA1—atherosclerosis	1.15e-06	1.62e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—GSTM1—atherosclerosis	1.15e-06	1.62e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—HMOX1—atherosclerosis	1.13e-06	1.59e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—LPL—atherosclerosis	1.13e-06	1.59e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ALOX5AP—atherosclerosis	1.12e-06	1.57e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ALOX15—atherosclerosis	1.12e-06	1.57e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—APOA2—atherosclerosis	1.12e-06	1.57e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PLA2G2A—atherosclerosis	1.12e-06	1.57e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ABCG5—atherosclerosis	1.11e-06	1.55e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—GPX1—atherosclerosis	1.1e-06	1.55e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—LTA4H—atherosclerosis	1.1e-06	1.54e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ABCG8—atherosclerosis	1.1e-06	1.54e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—APOB—atherosclerosis	1.09e-06	1.52e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	1.08e-06	1.52e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—ALB—atherosclerosis	1.08e-06	1.51e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—CD36—atherosclerosis	1.08e-06	1.51e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—LPA—atherosclerosis	1.07e-06	1.5e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—GSTM1—atherosclerosis	1.06e-06	1.48e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PIK3CG—atherosclerosis	1.05e-06	1.48e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PIK3CG—atherosclerosis	1.05e-06	1.48e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—HMOX1—atherosclerosis	1.05e-06	1.47e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—BGN—atherosclerosis	1.04e-06	1.45e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—LPL—atherosclerosis	1.04e-06	1.45e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—NOS3—atherosclerosis	1.03e-06	1.44e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—APOA5—atherosclerosis	1.03e-06	1.44e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—MTHFR—atherosclerosis	1.02e-06	1.43e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PPARG—atherosclerosis	1.02e-06	1.42e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PPARG—atherosclerosis	1.02e-06	1.42e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—GPX1—atherosclerosis	1.01e-06	1.42e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—APOB—atherosclerosis	1.01e-06	1.41e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PPARA—atherosclerosis	1e-06	1.4e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—INS—atherosclerosis	9.97e-07	1.4e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—INS—atherosclerosis	9.97e-07	1.4e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PLA2G1B—atherosclerosis	9.88e-07	1.38e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—CD36—atherosclerosis	9.85e-07	1.38e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	9.79e-07	1.37e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—GSTM1—atherosclerosis	9.78e-07	1.37e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—AGT—atherosclerosis	9.68e-07	1.36e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—LPL—atherosclerosis	9.6e-07	1.35e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ALOX5—atherosclerosis	9.55e-07	1.34e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—APOE—atherosclerosis	9.49e-07	1.33e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PTGS2—atherosclerosis	9.41e-07	1.32e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—CAV1—atherosclerosis	9.4e-07	1.32e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—APOA1—atherosclerosis	9.38e-07	1.31e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—GPX1—atherosclerosis	9.37e-07	1.31e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—MTHFR—atherosclerosis	9.34e-07	1.31e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	9.19e-07	1.29e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PPARA—atherosclerosis	9.16e-07	1.28e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—ALB—atherosclerosis	9.14e-07	1.28e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—ALB—atherosclerosis	9.14e-07	1.28e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CD36—atherosclerosis	9.12e-07	1.28e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—AGT—atherosclerosis	8.87e-07	1.24e-05	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—AKT1—atherosclerosis	8.83e-07	1.24e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—NOS3—atherosclerosis	8.75e-07	1.23e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—NOS3—atherosclerosis	8.75e-07	1.23e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ABCG1—atherosclerosis	8.71e-07	1.22e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—APOE—atherosclerosis	8.69e-07	1.22e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—MTHFR—atherosclerosis	8.65e-07	1.21e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—CAV1—atherosclerosis	8.61e-07	1.21e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—APOA1—atherosclerosis	8.59e-07	1.2e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PIK3CG—atherosclerosis	8.56e-07	1.2e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—NAMPT—atherosclerosis	8.56e-07	1.2e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—LIPC—atherosclerosis	8.51e-07	1.19e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PPARA—atherosclerosis	8.48e-07	1.19e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—APOC3—atherosclerosis	8.46e-07	1.18e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—LDLR—atherosclerosis	8.4e-07	1.18e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PPARG—atherosclerosis	8.26e-07	1.16e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—AGT—atherosclerosis	8.22e-07	1.15e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CETP—atherosclerosis	8.21e-07	1.15e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—FABP4—atherosclerosis	8.19e-07	1.15e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—LCAT—atherosclerosis	8.19e-07	1.15e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—INS—atherosclerosis	8.1e-07	1.14e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	8.06e-07	1.13e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—APOE—atherosclerosis	8.05e-07	1.13e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—APOA4—atherosclerosis	8.03e-07	1.13e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PTGS2—atherosclerosis	8e-07	1.12e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PTGS2—atherosclerosis	8e-07	1.12e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CAV1—atherosclerosis	7.98e-07	1.12e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—APOA1—atherosclerosis	7.96e-07	1.11e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CYP7A1—atherosclerosis	7.89e-07	1.11e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—SCARB1—atherosclerosis	7.86e-07	1.1e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PIK3CG—atherosclerosis	7.85e-07	1.1e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PPARG—atherosclerosis	7.57e-07	1.06e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—ALB—atherosclerosis	7.43e-07	1.04e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—INS—atherosclerosis	7.43e-07	1.04e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—HMGCR—atherosclerosis	7.42e-07	1.04e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CYP27A1—atherosclerosis	7.3e-07	1.02e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	7.28e-07	1.02e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PIK3CG—atherosclerosis	7.26e-07	1.02e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—NOS3—atherosclerosis	7.11e-07	9.96e-06	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PPARG—atherosclerosis	7.01e-07	9.82e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	6.92e-07	9.69e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—APOA2—atherosclerosis	6.92e-07	9.69e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ALOX15—atherosclerosis	6.92e-07	9.69e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	6.92e-07	9.69e-06	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—INS—atherosclerosis	6.88e-07	9.63e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ABCG5—atherosclerosis	6.83e-07	9.57e-06	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—ALB—atherosclerosis	6.81e-07	9.54e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ABCA1—atherosclerosis	6.62e-07	9.27e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—LPA—atherosclerosis	6.6e-07	9.24e-06	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—NOS3—atherosclerosis	6.51e-07	9.12e-06	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PTGS2—atherosclerosis	6.5e-07	9.11e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—BGN—atherosclerosis	6.39e-07	8.95e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—APOA5—atherosclerosis	6.33e-07	8.86e-06	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—ALB—atherosclerosis	6.3e-07	8.83e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	6.09e-07	8.53e-06	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—NOS3—atherosclerosis	6.03e-07	8.45e-06	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PTGS2—atherosclerosis	5.96e-07	8.34e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ALOX5—atherosclerosis	5.88e-07	8.24e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—HMOX1—atherosclerosis	5.68e-07	7.95e-06	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PTGS2—atherosclerosis	5.52e-07	7.73e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—APOB—atherosclerosis	5.44e-07	7.62e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GSTM1—atherosclerosis	5.29e-07	7.41e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—NAMPT—atherosclerosis	5.27e-07	7.39e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—LIPC—atherosclerosis	5.24e-07	7.34e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—APOC3—atherosclerosis	5.21e-07	7.3e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—LPL—atherosclerosis	5.19e-07	7.27e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—LDLR—atherosclerosis	5.18e-07	7.25e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GPX1—atherosclerosis	5.07e-07	7.1e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CETP—atherosclerosis	5.06e-07	7.08e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CD36—atherosclerosis	4.93e-07	6.91e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—SCARB1—atherosclerosis	4.84e-07	6.78e-06	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—AKT1—atherosclerosis	4.73e-07	6.62e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—MTHFR—atherosclerosis	4.67e-07	6.55e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PPARA—atherosclerosis	4.59e-07	6.42e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—HMGCR—atherosclerosis	4.57e-07	6.41e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—AGT—atherosclerosis	4.44e-07	6.22e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—APOE—atherosclerosis	4.35e-07	6.1e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CAV1—atherosclerosis	4.31e-07	6.04e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—APOA1—atherosclerosis	4.3e-07	6.03e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ABCA1—atherosclerosis	4.08e-07	5.71e-06	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—AKT1—atherosclerosis	4.02e-07	5.63e-06	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—AKT1—atherosclerosis	4.02e-07	5.63e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PIK3CG—atherosclerosis	3.93e-07	5.5e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PPARG—atherosclerosis	3.79e-07	5.31e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—INS—atherosclerosis	3.72e-07	5.21e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—HMOX1—atherosclerosis	3.5e-07	4.9e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ALB—atherosclerosis	3.41e-07	4.78e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—APOB—atherosclerosis	3.35e-07	4.69e-06	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—AKT1—atherosclerosis	3.27e-07	4.58e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—NOS3—atherosclerosis	3.26e-07	4.57e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GSTM1—atherosclerosis	3.26e-07	4.57e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—LPL—atherosclerosis	3.2e-07	4.48e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GPX1—atherosclerosis	3.12e-07	4.37e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CD36—atherosclerosis	3.04e-07	4.26e-06	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—AKT1—atherosclerosis	2.99e-07	4.19e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PTGS2—atherosclerosis	2.98e-07	4.18e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—MTHFR—atherosclerosis	2.88e-07	4.03e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PPARA—atherosclerosis	2.83e-07	3.96e-06	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—AKT1—atherosclerosis	2.77e-07	3.88e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—AGT—atherosclerosis	2.74e-07	3.83e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—APOE—atherosclerosis	2.68e-07	3.76e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CAV1—atherosclerosis	2.66e-07	3.72e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—APOA1—atherosclerosis	2.65e-07	3.71e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PIK3CG—atherosclerosis	2.42e-07	3.39e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PPARG—atherosclerosis	2.34e-07	3.27e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—INS—atherosclerosis	2.29e-07	3.21e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ALB—atherosclerosis	2.1e-07	2.94e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—NOS3—atherosclerosis	2.01e-07	2.81e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PTGS2—atherosclerosis	1.84e-07	2.57e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—AKT1—atherosclerosis	1.5e-07	2.1e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—AKT1—atherosclerosis	9.23e-08	1.29e-06	CbGpPWpGaD
